Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy and Safet

Indication
ADHD; ADHD - Combined Type; Attention Deficit Hyper Activity

Other upcoming events for CING

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy and Safet

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy and Safet — CING Phase 3 Readout | BioSniper